Article
Investigating Therapeutic Efficacy of Dacarbazine and Temozolomide, Alone and in Combination with BRAF(V600E) siRNA in A375 Human Melanoma Cell Line
2024-04-03
Abstract excerpt
<title>Abstract</title> <p>Melanoma is one of the variable nature and deadliest form of skin cancers and the mutations play a major role in its development. It has faced many challenges in treatment and has led to the orientation of individual therapies to combined therapy. the present study is aimed at determining the combination therapeutic effects of Dacarbazine, Temozolomide with siRNA BRAF (V600E) in the A37...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3d7f86c0-70bc-5ee5-b519-d62317d80436
- DOI
- 10.21203/rs.3.rs-4192121/v1
